本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iTeos Therapeutics

10.15
0.0000
成交量:- -
成交額:1.12億
市值:4.49億
市盈率:-2.17
高:10.15
開:10.15
低:10.15
收:10.15
52周最高:17.63
52周最低:4.80
股本:4,420.54萬
流通股本:3,323.73萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.6756
每股收益(LYR):-3.3210
淨資產收益率:-34.97%
總資產收益率:-18.49%
市淨率:0.91
市盈率(LYR):-3.06

資料載入中...

2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/03

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/13

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

重要事件披露

8-K - Current report
2022/01/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership